Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.

By P. Eggimann, J. Garbino, Didier Pittet. Lancet. Infectious Diseases (Print), 2003

932 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/cb2fa5cce8475344b473479d2759c5e304f11a81

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Pfaller
2. D. Diekema
3. A. Kramer
4. G. Kampf
5. J. Guinea

In Infectious Diseases

1. M. Pfaller
2. D. Diekema
3. A. Kramer
4. G. Kampf
5. K. Poole
6. J. Guinea

Citations in the corpus

• Epidemiology of Invasive Mycoses in North America (2010, background): “2008) and has been shown to be an additional independent risk factor (Blumberg et al. 2001; Eggimann et al. 2003; Ostrosky-Zeichner. 2004; Saiman et al. 2000; Wenzel et al. 2005).”
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007, background): “transmission of Candida among patients and has been shown to be an additional independent risk factor (23, 70, 181, 255, 308).”
• Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. (2012, background): “In fact, some epidemiologic studies (Krcmery, 1999a; Kontoyiannis et al., 2001; Eggimann et al., 2003; Colombo et al., 2007) documented that C. tropicalis was associated with higher mortality than other NCAC species and C. albicans.”
• Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “Candida species belong to the normal microbiota of an individual’s mucosal oral cavity, gastrointestinal tract and vagina (Shao et al., 2007), and are responsible for various clinical manifestations from mucocutaneous overgrowth to bloodstream infections (Eggimann et al., 2003).”
• Epidemiologic Background of Hand Hygiene and Evaluation of the Most Important Agents for Scrubs and Rubs (2004, background): “have become more common among critically ill patients in the last decades (89, 128, 163, 342); the contribution of non-albicans Candida spp.”
• Activity of phenolic compounds from plant origin against Candida species (2015, background): “…living smoothly in the inner warm creases and crevices of the gastrointestinal (GI) tract (and vaginal tract), they are able to cause problems, mainly vaginal infections (Asmundsdóttir et al., 2009; Brunke and Hube, 2013; Eggimann et al., 2003a; McCullough et al., 1996; Tsai et al., 2013).”
• Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. (2012, background): “Moreover, longitudinal studies have detected a global shift in epidemiology toward non-albicans Candida species, particularly Candida glabrata [14–22].”